Listening and learning remains the key to personalising therapy, says Jan Vermorken, who spent a career specialising in the cruellest of cancers. Download full article
Many cancer medications are being prescribed by the month, year, or even indefinitely, tolerability is increasingly more important, yet patients have no direct input into evaluating a new drug. Download full article
Angelo Di Leo cut his research teeth on the first studies that looked for biological markers that could predict which patients respond to what, and he’s never looked back. Download full article
How can you get the greatest efficacy from neurotoxic drugs without putting patients at risk of acute or chronic damage to their nervous system? Download full article
We republish here a article that earned health journalist Nicola Kuhrt a Best Cancer Reporter Award. Download full article